Lauxera Capital Partners

Download PDF Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond Financing will further accelerate the already successful early commercial rollout of VitaSmart HOPE System Co

Download PDF Full article in french here Private equity is going through a period of heightened selectivity. Rising interest rates, multiple compression, and a lack of liquidity have redrawn the contours of the business. Against this backdrop, the Medtech

Download PDF Full article here Ce deuxième millésime compte Sagard, Flexstone et Morgan Stanley IM parmi ses nouveaux souscripteurs. Six mois après l'annonce d'un premier closing à hauteur de 400 M€, le gérant spécialisé dans la healthtech clôture la coll

Download PDF Full article here Lauxera Capital Partners just raised €520 million for its new Lauxera Growth II fund. The firm announced closing the fund on May 19, which attracted more money than it originally targeted, in less than 18 months. Over 90 per

Download PDF Full article here Lauxera Capital Partners has raised a €520 million second fund focused on scaling European healthtech companies internationally, underscoring continued investor appetite for healthcare technology platforms that can bridge Eu

Download PDF Full article here Lauxera Capital Partners has closed a €520 million oversubscribed second fund built on a controversial thesis: Europe may invent world-class healthtech, but America still controls the scaleup game. According to Pierre Mousti

Download PDF Full article here Lauxera Capital Partners has closed its second healthtech growth fund at €520 million, exceeding its €500 million hard cap The firm invests between €20 and €50 million in European healthtech companies across medical devices,

Download PDF Full article here Objectives and Fund Close Lauxera Capital Partners has held the final close of its second fund, exceeding its hard-cap target and nearly doubling the size of its debut vehicle. The fundraise was completed recently and saw mo

Download PDF Full article here Lauxera Capital Partners, a Paris, France- and San Francisco, CA-based growth-buyout and growth equity firm focused on Healthtech companies, closed Lauxera Growth Il, at €520m. Backers included both returning and new Limited